Illumina provides sequencing and array solutions to advance genomic research. Their products include instruments, kits, reagents, software, and analysis services.

Illumina

BaseSpace Informatics Suite

Illumina For Startups

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Oxford Nanopore Technologies

SomaLogic

Twist Bioscience

GenoLogics

Ginkgo Bioworks

Grail

Helixis

Bank of America

Lombard Odier

Chase Capital Partners

Chevron Technology Ventures

ARCH Venture Partners

State Farm

Tredegar Investments

Venrock

CW Group

The "chewing gum," made from birch bark pitch and saliva, likely served as glue for tools. Researchers analyzed the #DNA in the gum, revealing the Stone Age teenagers' diet, including deer, trout, apple, duck, fox, and hazelnuts.

May the Year of the Dragon bring you joy, prosperity, and good luck! 🐲 

In 2023, we launched a novel technology to help reach the darkest corners of the genome and make long-read sequencing accessible. Now, we have built upon Illumina Complete Long Read technology with a new highly accurate, targeted long-read solution—compatible with predesigned and fully custom panels—offering greater flexibility for long-read sequencing.
 
Why? To help scientists access more of the genome and find answers to improve human health.

Learn more about Illumina Complete Long Read Prep with Enrichment:
https://bit.ly/3Oliav7


Good things come in threes, and the lineup of #NovaSeqX flow cells are no different. The addition of the 1.5B flow cell to the reagent kit portfolio provides unmatched flexibility to take on smaller batch or pilot projects. 

Scale up your way with the NovaSeq X Series: https://bit.ly/3u8LlKS

COM:ILLUMINA

Illumina

Financials Not Available